Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Akcea Therapeutics Inc (AKCA)

Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,846,054
  • Shares Outstanding, K 101,599
  • Annual Sales, $ 488,540 K
  • Annual Income, $ 40,770 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.45
  • Price/Sales 3.77
  • Price/Cash Flow 35.60
  • Price/Book 3.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.54
  • Most Recent Earnings $-0.49 on 08/04/20
  • Next Earnings Date 11/03/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.34
  • Number of Estimates 2
  • High Estimate -0.26
  • Low Estimate -0.41
  • Prior Year -0.34
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.05 +0.66%
on 09/21/20
18.22 -0.27%
on 09/28/20
+0.03 (+0.17%)
since 09/09/20
3-Month
9.81 +85.22%
on 08/05/20
19.65 -7.53%
on 08/31/20
+4.88 (+36.72%)
since 07/09/20
52-Week
8.00 +127.13%
on 03/16/20
21.70 -16.29%
on 12/16/19
-1.57 (-7.95%)
since 10/09/19

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Akcea Therapeutics, Inc. is a biopharmaceutical company. It focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. The Company's drug pipeline consists of volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 18.20
1st Resistance Point 18.18
Last Price 18.17
1st Support Level 18.14
2nd Support Level 18.12
3rd Support Level N/A

See More

52-Week High 21.70
Last Price 18.17
Fibonacci 61.8% 16.47
Fibonacci 50% 14.85
Fibonacci 38.2% 13.24
52-Week Low 8.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar